Schedule 13D ownership disclosure

ALAUNOS THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 98973P309

Event date: 2025-06-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • WaterMill Asset Management Corp.

    Shares: 166,963.00 · Class: 7.6%

  • Postma Robert WReported CIK 0001827847

    Shares: 199,796.00 · Class: 9.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-001912
Form type
SCHEDULE 13D
Filer
Alaunos Therapeutics, Inc.
CIK
CIK 1107421
Filed
Jul 01, 2025
Reporting period
Jun 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub